Epiglottitis epidemiology and demographics
|
Epiglottitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Epiglottitis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Epiglottitis epidemiology and demographics |
|
Risk calculators and risk factors for Epiglottitis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Prince Tano Djan, BSc, MBChB [2]
Overview
Epidemiology and demographics
Incidence and prevalence
With the advent of Haemophilus influenza type b vaccine, the prevalence of epiglottitis has reduced by >90%.[1]
In North America, approximatley 1.3 per 100,000 children are affected per year. In adults, th incidence is between 1 and 4 per 100,000 per year.[2]
Gender
Age
The disease used to be mostly found in pediatric age group between 3 to 5 years. However, recent trend favors adults as most commonly affected individuals.[3]
Race
Developed vs developing countries
It occurs more commonly in the developing world.[4]
References
- ↑ Des Jardins, Terry (2015). Clinical Manifestations & Assessment of Respiratory Disease (7 ed.). Elsevier Health Sciences. p. 529. ISBN 9780323358972.
- ↑ Textbook of Adult Emergency Medicine (4 ed.). Elsevier Health Sciences. 2014. p. 291. ISBN 9780702054389. Retrieved 15 July 2016.
- ↑ Lichtor JL, Roche Rodriguez M, Aaronson NL, Spock T, Goodman TR, Baum ED (2016). "Epiglottitis: It Hasn't Gone Away". Anesthesiology. 124 (6): 1404–7. doi:10.1097/ALN.0000000000001125. PMID 27031010.
- ↑ Boons, Geert-Jan (2009). Carbohydrate-Based Vaccines and Immunotherapies. Hoboken: John Wiley & Sons. p. 1222. ISBN 9780470473276.